Table 1.

Primary efficacy results in AURA extension and AURA2 trials determined by RECIST v1.1 according to BICR

AURA extension (n = 201)AURA2 (n = 210)Overalla (N = 411)
ORR (95% CI), (%)57 (50–64)61 (54–68)59 (54–64)
CR (%)010.5
PR (%)576059
  • aPooled analysis of AURA extension and AURA2.

  • Abbreviations: CR, complete response; PR, partial response.